학술논문

Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial
Document Type
Article
Source
In Annals of Oncology May 2014 25(5):987-991
Subject
Language
ISSN
0923-7534